AAFV - Alperovitch,A.; Will,R.G. - Predicting the size of the vCJD epidemic in France - Comptes Rendus de l'Academie des Sciences. Serie III, Sciences de la Vie 2002 Jan; 325(1): 33-6
AAFW - Alperovitch,A. - Variant CJD: finding a needle in a haystack? - Hospital Medicine 2000 Feb; 61(2): 145
AAFX - Alperovitch,A. - [The new variant of Creutzfeldt-Jakob disease: several questions without response] - Le nouveau variant de la maladie de Creutzfeldt-Jakob: quelques questions sans reponse. - Revue d'Épidémiologie et de Santé Publique 1999 Sep; 47(4): 313-4
AAFZ - Alperovitch,A.; Zerr,I.; Pocchiari,M.; Mitrova,E.; de Pedro Cuesta,J.; Hegyi,I.; Collins,S.J.; Kretzschmar,H.A.; van Duijn,C.M.; Will,R.G. - Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease - Lancet 1999 May 15; 353(9165): 1673-4
AAFY - Alperovitch,A. - Commentary: uncertainty over length of incubation tempers optimism. - British Medical Journal 1999 Apr 17; 318(7190): 1045
AAGA - Alperovitch,A.; Delasnerie-Laupretre,N.; Brandel,J.P. - [A note on the epidemiology of Creutzfeldt-Jakob syndrome] - Le point sur l'epidemiologie de la maladie de Creutzfeldt-Jakob - Revue Neurologique 1998 Feb; 154(2): 139-41
APBI - Alperovitch,A.; Bradley,R.; Diringer,H.; Gibbs,J.; Horaud,F.; Ironside,J.W.; Longbottom,H.; Losos,J.; Pattison,J.R.; Schonberger,L.; Smith,P.; Somogyi,A.; Vandevelde,M. - Public-health issues and clinical and neurological characteristics of the new variant of Creutzfeldt-Jakob- disease and other human and animal transmissible spongiform encephalopathies - memorandum from 2 WHO meetings - Bulletin of the World Health Organization 1996; 74(N5): 453-63
AAGB - Alperovitch,A.; Brown,P.; Weber,T.; Pocchiari,M.; Hofman,A.; Will,R. - Incidence of Creutzfeldt-Jakob disease in Europe in 1993 - Lancet 1994 Apr 9; 343(8902): 918
AAGR - Amouyel,P.; Alperovitch,A.; Delasnerie-Laupretre,N.; Laplanche,J.L. - Apolipoprotein E in Creutzfeldt-Jakob disease. French Research Group on Epidemiology of Human Spongiform Encephalopathies. - Lancet 1995 Mar 4; 345(8949): 595-6
ANPE - Berr,C.; Helbecque,N.; Sazdovitch,V.; Mohr,M.; Amant,C.; Amouyel,P.; Alperovitch,A.; Hauw,J.J. - Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing - Acta Neuropathologica 2003 Jul, 106(1): 71-4
ABHH - Berr,C.; Richard,F.; Dufouil,C.; Amant,C.; Alperovitch,A.; Amouyel,P. - Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study. - Neurology 1998 Sep; 51(3): 734-7
ABIZ - Billette de Villemeur,T.B.; Deslys,J.P.; Pradel,A.; Soubrie,C.; Alperovitch,A.; Tardieu,M.; Chaussain,J.L.; Hauw,J.J.; Dormont,D.; Ruberg,M.; Agid,Y. - Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France - Neurology 1996 Sep; 47(3): 690-5
AWRL - Brandel,J.P.; Salomon,D.; Alperovitch,A. - [vCJD epidemiology in France] - Epidemiologie de la variante de la maladie de Creutzfeldt-Jakob en France - Transfusion Clinique et Biologique 2006 Nov; 13(5): 304-6
ATND - Brandel,J.P.; Haik,S.; Delasnerie-Laupretre,N.; Le Masson,V.; Salomon,D.; Laplanche,J.L.; Hauw,J.J.; Alperovitch,A. - Variant Creutzfeldt-Jakob in France - International Conference - Prion 2005: Between fundamentals and society's needs - 19.10.-21.10.2005, Congress Center Düsseldorf - Poster Session: Human prions, risk of blood products, and therapy HUMAN-01
AQIB - Brandel,J.P.; Delasnerie-Laupretre,N.; Alperovitch,A. - [Update on prion disease] - Le point sur les maladies a prions - Revue Neurologique 2003 Dec; 159(12): 1200-4
AOFD - Brandel,J.P.; Preece,M.; Brown,P.; Croes,E.A.; Laplanche,J.L.; Agid,Y.; Will,R.; Alperovitch,A. - Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK - Lancet 2003 Jul 12; 362(9378): 128-30
ABPO - Brandel,J.P.; Delasnerie-Laupretre,N.; Laplanche,J.L.; Hauw,J.J.; Alperovitch,A. - Diagnosis of Creutzfeldt-Jakob disease: Effect of clinical criteria on incidence estimates. - Neurology 2000 Mar 14; 54(5): 1095-9
ABPT - Brandel,J.P.; Delasnerie-Laupretre,N.; Laplanche,J.L.; Dormont,D.; Hauw,J.J.; Alperovitch,A. - [A study network of human spongiform encephalopathies: 1st results] - Reseau d'etudes des encephalopathies spongiformes humaines: premiers resultats. - Revue Neurologique 1994 Oct; 150(10): 684-8
ASOI - Chadeau-Hyam,M.; Alperovitch,A. - [Variant Creutzfeldt-Jakob disease in France: estimating the number of cases related to travel to the United Kingdom between 1980 and 1995] - Le nouveau variant de la maladie de Creutzfeldt-Jakob en France: estimation du nombre de cas attribuables a un sejour dans les iles britanniques entre 1980 et 1995. - Revue d'Épidémiologie et de Santé Publique 2005 Feb; 53(1): 15-24
AROL - Chadeau-Hyam,M.; Alperovitch,A. - Risk of variant Creutzfeldt-Jakob disease in France - International Journal of Epidemiology 2005 Feb; 34(1): 46-52
APGD - Chadeau-Hyam,M.; Tard,A.; Bird,S.M.; Le Guennec,S.; Bemrah,N.; Volatier,J.L.; Alperovitch,A. - Estimation of the exposure of the French population to the BSE agent: comparison of the 1980-95 consumption of beef products containing mechanically recovered meat in France and the UK, by birth cohort and gender. - Statistical Methods in Medical Research 2003 Jun; 12(3): 247-60
AUUS - Collins,S.J.; Sanchez-Juan,P.; Masters,C.L.; Klug,G.M.; van Duijn,C.M.; Poleggi,A.; Pocchiari,M.; Almonti,S.; Cuadrado Corrales,N.; de Pedro Cuesta,J.; Budka,H.; Gelpi,E.; Glatzel,M.; Tolnay,M.; Hewer,E.; Zerr,I.; Heinemann,U.; Kretzschmar,H.A.; Jansen,G.H.; Olsen,E.; Mitrova,E.; Alperovitch,A.; Brandel,J.P.; Mackenzie,J.; Murray,K.; Will,R.G. - Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease - Brain: A Journal of Neurology 2006 Sep; 129(9): 2278-87
AVNH - de Pedro Cuesta,J.; Glatzel,M.; Almazan,J.; Stoeck,K.; Mellina,V.; Puopolo,M.; Pocchiari,M.; Zerr,I.; Kretzschmar,H.A.; Brandel,J.P.; Delasnerie-Laupretre,N.; Alperovitch,A.; van Duijn,C.; Sanchez-Juan,P.; Collins,S.J.; Lewis,V.; Jansen,G.H.; Coulthart,M.B.; Gelpi,E.; Budka,H.; Mitrova,E. - Human transmissible spongiform encephalopathies in eleven countries: diagnostic pattern across time, 1993-2002. - BMC Public Health 2006; 6: 278
ADFE - Delasnerie-Laupretre,N.; Alperovitch,A. - [Epidemiology of Creutzfeldt-Jakob disease] - Epidemiologie de la maladie de Creutzfeldt-Jakob - Pathologie Biologie 1995 Jan; 43(1): 22-4
AEPJ - Giraud,P.; Alperovitch,A.; Chazot,G. - [Creutzfeld-Jakob disease] - Maladies de Creutzfeldt-Jakob - Revue du Praticien 1999 May 1; 49(9): 948-53
ASTO - Haik,S.; Brandel,J.P.; Salomon,D.; Sazdovitch,V.; Delasnerie-Laupretre,N.; Laplanche,J.L.; Faucheux,B.A.; Soubrie,C.; Boher,E.; Belorgey,C.; Hauw,J.J.; Alperovitch,A. - Compassionate use of quinacrine in Creutzfeldt-Jakob disease fails to show significant effects - Neurology 2004 Dec 28; 63(12): 2413-5
AOTS - Haik,S.; Brandel,J.P.; Salomon,D.; Sazdovitch,V.; Delasnerie-Laupretre,N.; Fierville,F.; Laplanche,J.L.; Faucheux,B.A.; Hauw,J.J.; Alperovitch,A. - Clinical and neuropathological features of CJD patients treated with Quinacrine in France - International Conference - Prion diseases: from basic research to intervention concepts - TSE-Forum, 08.10.-10.10.2003, Gasteig, München - Poster session - IV-26
AFFN - Hauw,J.J.; Sazdovitch,V.; Laplanche,J.L.; Peoc'h,K.; Kopp,N.; Kemeny,J.; Privat,N.; Delasnerie-Laupretre,N.; Brandel,J.P.; Deslys,J.P.; Dormont,D.; Alperovitch,A. - Neuropathologic variants of sporadic Creutzfeldt-Jakob disease and codon 129 of PrP gene - Neurology 2000 Apr 25; 54(8): 1641-6
AFRG - Huillard d'Aignaux,J.N.; Cousens,S.N.; Maccario,J.; Costagliola,D.; Alpers,M.P.; Smith,P.G.; Alperovitch,A. - The incubation period of kuru - Epidemiology 2002 Jul; 13(4): 402-8
ACZP - Huillard d'Aignaux,J.N.; Cousens,S.N.; Delasnerie-Laupretre,N.; Brandel,J.P.; Salomon,D.; Laplanche,J.L.; Hauw,J.J.; Alperovitch,A. - Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998 - International Journal of Epidemiology 2002 Apr; 31(2): 490-5
ACZQ - Huillard d'Aignaux,J.N.; Laplanche,J.L.; Delasnerie-Laupretre,N.; Brandel,J.P.; Peoc'h,K.; Salomon,D.; Hauw,J.J.; Alperovitch,A. - Trends in mortality from sporadic Creutzfeldt-Jakob disease in France 1992-7 - Journal of Neurology, Neurosurgery and Psychiatry 2000 Jun; 68(6): 787-9
AFRE - Huillard d'Aignaux,J.N.; Costagliola,D.; Maccario,J.; Billette de Villemeur,T.B.; Brandel,J.P.; Deslys,J.P.; Hauw,J.J.; Chaussain,J.L.; Agid,Y.; Dormont,D.; Alperovitch,A. - Incubation period of Creutzfeldt-Jakob disease in human growth hormone recipients in France - Neurology 1999 Oct 12; 53(6): 1197-201
AFRF - Huillard d'Aignaux,J.N.; Alperovitch,A.; Maccario,J. - A statistical model to identify the contaminated lots implicated in iatrogenic transmission of Creutzfeldt-Jakob disease among French human growth hormone recipients - American Journal of Epidemiology 1998 Mar 15; 147(6): 597-604
ATVU - Ladogana,A.; Puopolo,M.; Croes,E.A.; Budka,H.; Jarius,C.; Collins,S.J.; Klug,G.M.; Sutcliffe,T.; Giulivi,A.; Alperovitch,A.; Delasnerie-Laupretre,N.; Brandel,J.P.; Poser,S.; Kretzschmar,H.A.; Rietveld,I.; Mitrova,E.; de Pedro Cuesta,J.; Martinez-Martin,P.; Glatzel,M.; Aguzzi,A.; Knight,R.S.G.; Ward,H.J.T.; Pocchiari,M.; van Duijn,C.M.; Will,R.G.; Zerr,I. - Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada - Neurology 2005 May 10; 64(9): 1586-91
AHAS - Laplanche,J.L.; Delasnerie-Laupretre,N.; Brandel,J.P.; Chatelain,J.C.; Beaudry,P.; Alperovitch,A.; Launay,J.M. - Molecular genetics of prion diseases in France. French Research Group on Epidemiology of Human Spongiform Encephalopathies. - Neurology 1994 Dec; 44(12): 2347-51
AQYH - Pocchiari,M.; Puopolo,M.; Croes,E.A.; Budka,H.; Gelpi,E.; Collins,S.J.; Lewis,V.; Sutcliffe,T.; Guilivi,A.; Delasnerie-Laupretre,N.; Brandel,J.P.; Alperovitch,A.; Zerr,I.; Poser,S.; Kretzschmar,H.A.; Ladogana,A.; Rietvald,I.; Mitrova,E.; Martinez-Martin,P.; de Pedro Cuesta,J.; Glatzel,M.; Aguzzi,A.; Cooper,S.A.; Mackenzie,J.; van Duijn,C.M.; Will,R.G. - Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies - Brain: A Journal of Neurology 2004 Oct; 127(10): 2348-59
AKGD - Ruffie,A.; Delasnerie-Laupretre,N.; Brandel,J.P.; Jaussent,I.; Dormont,D.; Laplanche,J.L.; Hauw,J.J.; Richardson,S.; Alperovitch,A. - [Incidence of Creutzfeldt-Jakob disease in France, 1992-1995] - Incidence de la maladie de Creutzfeldt-Jakob en France, 1992-1995 - Revue d'Épidémiologie et de Santé Publique 1997 Dec; 45(6): 448-53
AOZF - Sitzmann,L.; Brandel,J.P.; Delasnerie-Laupretre,N.; Laplanche,J.L.; Perret-Liaudet,A.; Fleury,H.; Alperovitch,A. - Could a Modification of Inclusion Criteria Lead to an Earlier Treatment of Patients With Sporadic CJD ? - International Conference - Prion diseases: from basic research to intervention concepts - TSE-Forum, 08.10.-10.10.2003, Gasteig, München - Poster session - DG-49
ALXX - van Duijn,C.M.; Delasnerie-Laupretre,N.; Masullo,C.; Zerr,I.; de Silva,R.N.; Wientjens,D.P.W.M.; Brandel,J.P.; Weber,T.; Bonavita,V.; Zeidler,M.; Alperovitch,A.; Poser,S.; Granieri,E.; Hofman,A.; Will,R.G. - Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). - Lancet 1998 Apr 11; 351(9109): 1081-5
AMFM - Ward,H.J.T.; Everington,D.; Croes,E.A.; Alperovitch,A.; Delasnerie-Laupretre,N.; Zerr,I.; Poser,S.; van Duijn,C.M. - Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. - Neurology 2002 Aug 27; 59(4): 543-8
AMOC - Will,R.G.; Alperovitch,A.; Poser,S.; Pocchiari,M.; Hofman,A.; Mitrova,E.; de Silva,R.N.; D'Alessandro,M.; Delasnerie-Laupretre,N.; Zerr,I.; van Duijn,C.M. - Descriptive epidemiology of Creutzfeldt-Jakob disease in six European countries, 1993-1995. EU Collaborative Study Group for CJD. - Annals of Neurology 1998 Jun; 43(6): 763-7
AMOF - Will,R.G.; Ironside,J.W.; Zeidler,M.; Cousens,S.N.; Estibeiro,K.; Alperovitch,A.; Poser,S.; Pocchiari,M.; Hofman,A.; Smith,P.G. - A new variant of Creutzfeldt-Jakob disease in the UK - Lancet 1996 Apr 6; 347(9006): 921-5